New guidelines for the treatment of seasonal allergic rhinitis

Andrzej Emeryk, Justyna Emeryk-Maksymiuk, Kamil Janeczek, Andrzej Emeryk, Justyna Emeryk-Maksymiuk, Kamil Janeczek

Abstract

The paper discusses the classification and forms of allergic rhinitis with a special focus on seasonal allergic rhinitis (SAR). The general principles of SAR management are presented, including the role of nasal glucocorticoids, nasal and oral antihistamines, and antileukotrienes. Based on the latest guidelines, the current rules for the selection of drugs in the therapy of SAR are given, paying special attention to the initial treatment. The aim of the paper is to present updated guidelines for the pharmacological management of patients with seasonal allergic rhinitis.

Keywords: adults; antihistamines; antileukotrienes; children; nasal glucocorticoids; seasonal allergic rhinitis.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Classification of AR and relationships between different AR forms

References

    1. Khan DA. Allergic rhinitis and asthma: epidemiology and common pathophysiology. Allergy Asthma Proc. 2014;35:357–61.
    1. Cauwenberge P, Bachert C, Passlacqua G, et al. Consensus statement on the treatment of allergic rhinitis. Allergy. 2000;55:116–34.
    1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen) Allergy. 2008;63(Suppl.86):8–160.
    1. Samoliński B, Sybilski AJ, Raciborski F, et al. Prevalence of rhinitis in Polish population according to ECAP (Epidemiology of Allergic Disorders in Poland) study. Otolaryngol Pol. 2009;63:324–30.
    1. Devillier P, Bousquet J, Salvator H, et al. In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures. Clin Exp Allergy. 2016;46:1456–64.
    1. Zhou S, Hur K, Shen J, Wrobel B. Impact of sinonasal disease on depression, sleep duration, and productivity among adults in the United States. Laryngoscope Investig Otolaryngol. 2017;2:288–94.
    1. Hoehle LP, Speth MM, Phillips KM, et al. Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy. 2017;31:235–9.
    1. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 suppl):S1–84.
    1. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis executive summary. Otolaryngol Head Neck Surg. 2015;152:197–206.
    1. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl):147–334.
    1. Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the allergic rhinitis and its impact on asthma severity items. J Allergy Clin Immunol. 2007;120:359–65.
    1. Johannson SGO, Hourihane JOB, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813–24.
    1. Muraro A, Lemanske RF, Jr, Hellings PW, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137:1347–58.
    1. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23–34.
    1. Samoliński B. Raport z badań przeprowadzonych w latach 2006-2008 w oparciu o metodologię ECRHS II i ISAAC. Warszawa: Uniwersytet Medyczny w Warszawie; 2008. ECAP – Epidemiologia Chorób Alergicznych w Polsce.
    1. Rapiejko P, Lipiec A, Samoliński B. Podstawy etiopatogenezy alergicznego nieżytu nosa. In: Emeryk A, editor. Alergiczny nieżyt nosa u dzieci. Poznan: Termedia; 2010.
    1. Rapiejko P. Sezon pylenia roślin w Polsce w 2016 roku. Alergia. 2016;3:14–6.
    1. r.
    1. Samoliński B, Arcimowicz M, editors. Polskie Standardy Leczenie Nieżytów Nosa (PoSLeNN). Stanowisko Panelu Ekspertów Polskiego Towarzystwa Alergologicznego. Alerg Pol. 2013;(Suppl 1):17–167.
    1. Bousquet J, Schünemann HJ, Hellings PW, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138:367–74.
    1. Juel-Berg N, Darling P, Bolvig J, et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2017;31:19–28.
    1. Gane J, Buckley R. Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2013;1:65–74.
    1. Wei C. The efficacy and safety of H1-antihistamine versus montelukast for allergic rhinitis: a systematic review and meta-analysis. Biomed Pharmacother. 2016;83:989–97.
    1. Meltzer EO. Intranasal anticholinergic therapy of rhinorrhea. J Allergy Clin Immunol. 1992;90:1055–64.
    1. Tsabouri S, Tseretopoulou X, Priftis K, Ntzani EE. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol Pract. 2014;2:332–40.
    1. Meltzer EO. Pharmacotherapeutic strategies for allergic rhinitis: matching treatment to symptoms, disease progression, and associated conditions. Allergy Asthma Proc. 2013;34:301–11.
    1. Roberts P, Xatzipsalti M, Bornego LM, et al. Paediatric rhinitis: position paper of the European Academy of Allergology and Clinical Immunology. Allergy. 2013;68:1102–16.
    1. Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70:1372–92.
    1. Klimek L, Bergmann KC, Biedermann T, et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC) Allergo J Int. 2017;26:16–24.
    1. Rapiejko P. Elektroniczne kwestionariusze monitorujące objawy ułatwią diagnostykę i leczenie alergicznego nieżytu nosa. Alergoprofil. 2016;12:153–9.
    1. May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39:2410–9.
    1. Carr WW, Yawn BP. Management of allergic rhinitis in the era of effective over-the-counter treatments. Postgrad Med. 2017;129:572–80.
    1. Brożek JL, Baena-Cagnani CE, Bonini S, et al. Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update. Allergy. 2008;63:38–46.
    1. Terracciano L, Brozek J, Compalati E, Schunemann H. GRADE system: new paradigm. Curr Opin Allergy Clin Immuno. 2010;10:377–83.
    1. Dykewicz MS, Wallace DV, Baroody F, et al. Treatment of seasonal allergic rhinitis. An evidence-based focused 2017 guideline update. Practice Guideline. Ann Allergy Asthma Immunol. 2017;119:489–511.
    1. . Available at: 10.01.2018.
    1. Hellings PW, Dobbels F, Denhaerynck K, et al. Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transl Allergy. 2012;2:9.
    1. . Available at: 10.01.2018.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren